{"id":334901,"date":"2024-11-12T10:00:12","date_gmt":"2024-11-12T04:30:12","guid":{"rendered":"https:\/\/www.scconline.com\/blog\/?p=334901"},"modified":"2024-11-18T11:01:27","modified_gmt":"2024-11-18T05:31:27","slug":"up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news","status":"publish","type":"post","link":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/","title":{"rendered":"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information"},"content":{"rendered":"
\n

Commercial Court, Gautam Budh Nagar<\/span>: A suit was filed by Jubilant Generics Ltd., (plaintiff) a pharmaceutical company seeking a permanent injunction to prevent the unauthorized use and disclosure of a confidential product dossier related to the manufacturing of certain pharmaceutical products. Avnish Saxena, J., granted injunction, restraining the defendants from further manufacturing, distributing, or using the confidential dossier and related products and directed the defendants to return or destroy all copies of the product dossier in their possession, reaffirming the plaintiff’s right to safeguard its intellectual property against unauthorized use.<\/p>\n

The plaintiff had entered into a confidentiality and non-disclosure agreement with Jamp Pharmaceuticals Corporation, a Canadian company, under which a product dossier containing confidential chemical formulations and research data for medicines such as Amlodipine, Losartan, and Citalopram was shared. This dossier, the result of extensive research and development by the plaintiff, was provided to Jamp Pharma under a license agreement that strictly limited its use to manufacturing for distribution solely within Canada. The dispute arose when Jubilant discovered that Jamp Pharma’s Indian subsidiary (defendant 4) had allegedly shared this dossier with other defendants in India for the purpose of manufacturing these drugs locally, in direct violation of the confidentiality agreement. The plaintiff claimed this breach could lead to unauthorized use, manufacturing, and distribution of its proprietary formulations within India, potentially harming its business interests, and thus sought legal remedies to prevent further misuse.<\/p>\n

The plaintiff sought a decree of permanent injunction to restrain the defendants from using or further distributing the product dossier, and also prayed for ex parte interim injunction to stop the defendants from manufacturing, distributing, or exporting the medicines because the product dossier, as a result of continuous research, qualified as a protected work under the Copyright Act, 1957<\/a>, and any unauthorized use or distribution by the defendants was a violation of intellectual property rights.<\/p>\n

In defense, defendant 4 contended that the agreement between the plaintiff and Jamp Pharma was governed by Canadian law and included an arbitration clause specifying arbitration in Canada. The defendants also claimed that the product dossier had not been transferred for use within India, and that the medicines manufactured were solely for export to Canada, not for sale in India. They denied any violation of the confidentiality agreement, asserting that no irreparable harm had been caused to the plaintiff as the manufacturing and export were in accordance with the terms of the agreement.<\/p>\n

The Court noted that the product dossier, consisting of chemical formulas and research data, appeared to be a unique creation of the plaintiff, which was protected under copyright law. Thus, the Court found that the plaintiff had made a prima facie case for breach of confidentiality and violation of intellectual property rights.<\/p>\n

The Court observed that if the defendants were allowed to continue manufacturing and distributing the products, the plaintiff’s business interests, and intellectual property rights could be severely damaged. The Court also acknowledged the plaintiff’s concern that the continued use and distribution of its product dossier could lead to irreversible financial and reputational damage, particularly if the medicines were distributed in a market beyond Canada. While the defendants argued that no harm had occurred as the products were being exported to Canada, the Court emphasized that the breach of confidentiality, if proven, would result in irreparable harm to the plaintiff.<\/p>\n

Thus, the Court granted an injunction restraining the defendants from manufacturing, distributing, or exporting the disputed medicines until further orders and directed to refrain from any actions that could lead to the further distribution or misuse of the plaintiff’s product dossier.<\/p>\n

[Jubilant Generics Ltd. v Medreichs Limited, 2024 SCC OnLine Dis Crt (All) 1<\/a>, decided on 07-11-2024<\/span>]<\/p>\n\n

Advocates who appeared in this case :<\/p>\n

For plaintiff:<\/span> Vaibhav Mittal and Vashistha Parashar<\/p>\n

For defendants:<\/span> Arjun Krishnan<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

The Court has upheld a restraint against Canada’s Jamp Pharma and associated third parties, preventing them from infringing upon Jubilant Generics Limited’s intellectual property rights and unauthorized use of its confidential product dossier reinforcing the importance of respecting cross-border confidentiality agreements in pharmaceutical manufacturing and distribution.<\/p>\n","protected":false},"author":67516,"featured_media":334910,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[3,4721],"tags":[75153,75157,72374,75148,75156,75151,75150,75149,75155,75158,72376,75159,75152,75154],"class_list":["post-334901","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-casebriefs","category-district-court","tag-confidentialdata","tag-confidentialityagreement","tag-intellectualproperty","tag-internationalipdispute","tag-iprlitigation","tag-iprprotection","tag-jamppharma","tag-jubilantgenerics","tag-legalinjunction","tag-patentrights","tag-pharmaceuticallaw","tag-pharmaindustry","tag-tradesecrets","tag-upcivilcourt"],"yoast_head":"\nUP Civil Court upholds restraint on Canada\u2019s Jamp Pharma safeguarding Jubilant Generics' IPR and confidential data| SCC Times<\/title>\n<meta name=\"description\" content=\"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\" \/>\n<meta property=\"og:description\" content=\"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/\" \/>\n<meta property=\"og:site_name\" content=\"SCC Times\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/scc.online\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-12T04:30:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-18T05:31:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"886\" \/>\n\t<meta property=\"og:image:height\" content=\"590\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arunima\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arunima\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/\",\"url\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/\",\"name\":\"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma safeguarding Jubilant Generics' IPR and confidential data| SCC Times\",\"isPartOf\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp\",\"datePublished\":\"2024-11-12T04:30:12+00:00\",\"dateModified\":\"2024-11-18T05:31:27+00:00\",\"author\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb\"},\"description\":\"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\",\"breadcrumb\":{\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage\",\"url\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp\",\"contentUrl\":\"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp\",\"width\":886,\"height\":590,\"caption\":\"UP Court upholds restraint on Canada\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.scconline.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#website\",\"url\":\"https:\/\/www.scconline.com\/blog\/\",\"name\":\"SCC Times\",\"description\":\"Bringing you the Best Analytical Legal News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.scconline.com\/blog\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb\",\"name\":\"Arunima\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g\",\"caption\":\"Arunima\"},\"url\":\"https:\/\/www.scconline.com\/blog\/post\/author\/scc-editor_9\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma safeguarding Jubilant Generics' IPR and confidential data| SCC Times","description":"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/","og_locale":"en_US","og_type":"article","og_title":"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information","og_description":"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information","og_url":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/","og_site_name":"SCC Times","article_publisher":"https:\/\/www.facebook.com\/scc.online\/","article_published_time":"2024-11-12T04:30:12+00:00","article_modified_time":"2024-11-18T05:31:27+00:00","og_image":[{"width":886,"height":590,"url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.jpg","type":"image\/jpeg"}],"author":"Arunima","twitter_card":"summary_large_image","twitter_title":"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information","twitter_misc":{"Written by":"Arunima","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/","url":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/","name":"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma safeguarding Jubilant Generics' IPR and confidential data| SCC Times","isPartOf":{"@id":"https:\/\/www.scconline.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage"},"image":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage"},"thumbnailUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp","datePublished":"2024-11-12T04:30:12+00:00","dateModified":"2024-11-18T05:31:27+00:00","author":{"@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb"},"description":"UP Civil Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information","breadcrumb":{"@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#primaryimage","url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp","contentUrl":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp","width":886,"height":590,"caption":"UP Court upholds restraint on Canada"},{"@type":"BreadcrumbList","@id":"https:\/\/www.scconline.com\/blog\/post\/2024\/11\/12\/up-court-restrains-jamp-pharma-protects-jubilant-generics-ip-confidential-data-legal-news\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.scconline.com\/blog\/"},{"@type":"ListItem","position":2,"name":"UP Court upholds restraint on Canada\u2019s Jamp Pharma and third parties from infringing Jubilant Generics Limited\u2019s IPR and confidential proprietary information"}]},{"@type":"WebSite","@id":"https:\/\/www.scconline.com\/blog\/#website","url":"https:\/\/www.scconline.com\/blog\/","name":"SCC Times","description":"Bringing you the Best Analytical Legal News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.scconline.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/12b21fd8f65a572f39f27151710e16cb","name":"Arunima","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.scconline.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8375ad8b08b1cbd970f4484d3218d81f3222a0ee3e463210f657780cb13e9569?s=96&d=mm&r=g","caption":"Arunima"},"url":"https:\/\/www.scconline.com\/blog\/post\/author\/scc-editor_9\/"}]}},"jetpack_featured_media_url":"https:\/\/www.scconline.com\/blog\/wp-content\/uploads\/2024\/11\/UP-Court-upholds-restraint-on-Canada.webp","jetpack_sharing_enabled":true,"jetpack-related-posts":[{"id":342902,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/03\/04\/up-court-restrains-jamp-pharma-jubilant-generics-copyright-infringement\/","url_meta":{"origin":334901,"position":0},"title":"UP Court restrains Jamp Pharma from using Jubilant Generics’ confidential data; Grants injunction against copyright infringement","author":"Arunima","date":"March 4, 2025","format":false,"excerpt":"The plaintiff alleged that Jamp Pharma breached the agreement by sharing the product dossiers with the defendants i.e., Indian pharmaceutical companies manufacturing the said products for Jamp Pharma. Since these defendants were not parties to the original agreements, the plaintiff contended that their use of the product dossiers constituted copyright\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Jubilant Generics","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/03\/Jubilant-Generics.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/03\/Jubilant-Generics.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/03\/Jubilant-Generics.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/03\/Jubilant-Generics.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":379124,"url":"https:\/\/www.scconline.com\/blog\/post\/2026\/03\/23\/sc-upholds-interim-relief-in-jamp-jubilant-dossiers-dispute\/","url_meta":{"origin":334901,"position":1},"title":"Supreme Court upholds interim relief in JAMP-Jubilant pharmaceutical product dossiers dispute","author":"Arushi","date":"March 23, 2026","format":false,"excerpt":"In the present case, Jubilant Generics alleged Jamp Pharma Canada of misusing its confidential pharmaceutical dossiers. Jubilant claims these were wrongly shared with Indian companies, leading to copyright and trade secret violations.","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Jubilant-JAMP dossiers dispute","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Jubilant-JAMP-dossiers-dispute.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Jubilant-JAMP-dossiers-dispute.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Jubilant-JAMP-dossiers-dispute.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2026\/03\/Jubilant-JAMP-dossiers-dispute.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":364955,"url":"https:\/\/www.scconline.com\/blog\/post\/2025\/10\/28\/pharma-copyright-case-all-hc-upheld-copyright-infringement-of-jubilant-generics-product-dossiers\/","url_meta":{"origin":334901,"position":2},"title":"Allahabad HC: No relief to Jamp India, VS International over copyright infringement of Jubilant Generic’s Product Dossiers","author":"Sonali Ahuja","date":"October 28, 2025","format":false,"excerpt":"\u201cOnce copyright infringement is the core relief, incidental or ancillary reliefs, whether based on confidentiality, trade secrets, or passing off, do not affect maintainability of the suit as a whole.\u201d","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"Pharma Copyright case","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Pharma-Copyright-case.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Pharma-Copyright-case.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Pharma-Copyright-case.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2025\/10\/Pharma-Copyright-case.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":298498,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/08\/04\/delhi-hc-grants-injunction-to-glaxo-group-for-its-various-marks-legal-news\/","url_meta":{"origin":334901,"position":3},"title":"Delhi High Court grants injunction in favour of Glaxo Group for its marks Betnovate-N, Betnovate-C, T-Bact, Cobadex, Zentel, Augmentin","author":"Simranjeet","date":"August 4, 2023","format":false,"excerpt":"\u201cThe comparison of the defendant's and the plaintiffs\u2019 marks will show that the defendant has not merely copied one mark or packaging but has deliberately adopted a series of marks, in packaging with almost identical colour combinations.\u201d","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"delhi high court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":296078,"url":"https:\/\/www.scconline.com\/blog\/post\/2023\/07\/05\/delhi-high-court-grants-injunction-to-sun-pharma-for-its-mark-instamet-legal-news\/","url_meta":{"origin":334901,"position":4},"title":"Delhi High Court restrains Glemark Pharmaceuticals from using \u201cINDAMET\u201d mark; grants injunction to Sun Pharma for its mark \u201cINSTAMET\u201d","author":"Simranjeet","date":"July 5, 2023","format":false,"excerpt":"The two competing marks \u201cISTAMET\u201d and \u201cINDAMET\u201d are clearly structurally and phonetically similar, and when seen from the eyes of consumer of average intelligence having imperfect recollection, there are high chances of confusion and deception. Confusion surrounding the mode of administration of a drug can lead to misuse and potential\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"delhi high court","src":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/www.scconline.com\/blog\/wp-content\/uploads\/2023\/05\/delhi-high-court.webp?resize=700%2C400&ssl=1 2x"},"classes":[]},{"id":232874,"url":"https:\/\/www.scconline.com\/blog\/post\/2020\/07\/27\/delhi-high-court-rejects-trademark-injunction-sought-by-pharmaceutical-company-creating-typhoid-vaccines\/","url_meta":{"origin":334901,"position":5},"title":"Delhi High Court rejects trademark injunction sought by pharmaceutical company creating Typhoid vaccines \u00a0","author":"Editor","date":"July 27, 2020","format":false,"excerpt":"Delhi High Court: V. Kameswar Rao J. rejected an application for permanent injunction by a pharmaceutical company against a rival brand, seeking an order to restraint it from infringing its registered trade mark. The plaintiff had trademarked the terms \u2018TCV\u2019 and \u2018Typbar-TCV\u2019 in 2012 in relation to a revolutionary Typhoid\u2026","rel":"","context":"In "Case Briefs"","block_context":{"text":"Case Briefs","link":"https:\/\/www.scconline.com\/blog\/post\/category\/casebriefs\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]}],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/334901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/users\/67516"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/comments?post=334901"}],"version-history":[{"count":0,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/posts\/334901\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media\/334910"}],"wp:attachment":[{"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/media?parent=334901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/categories?post=334901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scconline.com\/blog\/wp-json\/wp\/v2\/tags?post=334901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}